Sepsis, a spinout of Liverpool University, has secured £400,000 ($609,000) from a variety of sources to continue its development of treatments for blood poisoning.
The UK-based firm received equity investment from an unnamed source, funding through a SMART award, and an innovation voucher provided by state body Innovation UK.
Sepsis, spun out in 2010, is developing a hand held device which allows with the rapid diagnosis and treatment of blood poisoning, also known as sepsis. In the UK, around 100,000 people are admitted to hospital with the condition, and 37,000 of them will die as a result.
Cheng Hock Toh, who led the initial research into the device, said: “This is an important step in translating original research from Liverpool into a global test that can improve antibiotic treatment and save lives.”
